In summary, the cooperation between tumor-derived chemokines and host/adipose tissue-derived chemokines, particularly CCL2, through CCR2 signaling considerably contributes to tumor cell survival, proliferation, and metastasis (Fig. 5), which makes CCR2 a potential therapeutic target in cancer treatment. This evidence concerns the gene CCR2 and cancer.